From: Exosomal proteins as potential markers of tumor diagnosis
Exosomal proteins | Tumor | Body fluid | Isolation method | Detection method | Year | Ref |
---|---|---|---|---|---|---|
NY-ESO-1 | Lung | Plasma | Extracellular Vesicle Array | Extracellular Vesicle Array | 2016 | [66] |
PKG1, RALGAPA2, NFX1, TJP2 | Breast | Plasma | Ultracentrifugation | Parallel reaction monitoring (PRM) | 2017 | [2] |
Her2 | Breast | Plasma | Microfluidic chip | Microfluidic chip | 2017 | [70] |
Glypican-1 | Breast | Serum | Ultracentrifugation and FACS | FACS | 2016 | [5] |
Glypican-1 | Pancreatic | Serum | Ultracentrifugation and FACS | Flow-cytometry and ELISA | 2016 | [5] |
Glypican-1 | Colorectal | Plasma | Immunocapture assays | Flow-cytometry | 2017 | [76] |
CEA | Colorectal | Serum | Polymer precipitation | ELISA | 2017 | [46] |
AMPN VNN1, PIGR | Cholangiocarcinoma | Serum | Ultracentrifugation | Western blot | 2016 | [77] |
PSA | Prostate | Plasma | Filtration and ultracentrifugation | ELISA and nanoscale flow-cytometry | 2017 | [41] |
GGT1 | Prostate | Serum | Ultracentrifugation/DGC/SEC | Western blot and fluorescent probe | 2017 | [80] |
CD24, EpCAM, CA-125 | Ovarian | Plasma | Microfluidic ExoSearch Chip | Microfluidic ExoSearch Chip | 2016 | [86] |